• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嘌呤能 P2X7 受体作为辅助治疗耐药性癫痫的靶点。

The Purinergic P2X7 Receptor as a Target for Adjunctive Treatment for Drug-Refractory Epilepsy.

机构信息

Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.

International College of Pharmaceutical Innovation, Soochow University, Suzhou 215123, China.

出版信息

Int J Mol Sci. 2024 Jun 23;25(13):6894. doi: 10.3390/ijms25136894.

DOI:10.3390/ijms25136894
PMID:39000004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11241490/
Abstract

Epilepsy is one of the most common neurological diseases worldwide. Anti-seizure medications (ASMs) with anticonvulsants remain the mainstay of epilepsy treatment. Currently used ASMs are, however, ineffective to suppress seizures in about one third of all patients. Moreover, ASMs show no significant impact on the pathogenic mechanisms involved in epilepsy development or disease progression and may cause serious side-effects, highlighting the need for the identification of new drug targets for a more causal therapy. Compelling evidence has demonstrated a role for purinergic signalling, including the nucleotide adenosine 5'-triphosphate (ATP) during the generation of seizures and epilepsy. Consequently, drugs targeting specific ATP-gated purinergic receptors have been suggested as promising treatment options for epilepsy including the cationic P2X7 receptor (P27XR). P2X7R protein levels have been shown to be increased in the brain of experimental models of epilepsy and in the resected brain tissue of patients with epilepsy. Animal studies have provided evidence that P2X7R blocking can reduce the severity of acute seizures and the epileptic phenotype. The current review will provide a brief summary of recent key findings on P2X7R signalling during seizures and epilepsy focusing on the potential clinical use of treatments based on the P2X7R as an adjunctive therapeutic strategy for drug-refractory seizures and epilepsy.

摘要

癫痫是全球最常见的神经系统疾病之一。具有抗惊厥作用的抗癫痫药物(ASM)仍然是癫痫治疗的主要方法。然而,目前使用的 ASM 在大约三分之一的患者中无法有效抑制癫痫发作。此外,ASM 对癫痫发展或疾病进展中涉及的致病机制没有显著影响,并且可能会引起严重的副作用,这凸显了需要确定新的药物靶点,以进行更具因果关系的治疗。有强有力的证据表明,嘌呤能信号包括核苷酸三磷酸腺苷(ATP)在癫痫发作和癫痫的发生中发挥作用。因此,针对特定 ATP 门控嘌呤能受体的药物已被认为是癫痫的有前途的治疗选择,包括阳离子 P2X7 受体(P27XR)。已经表明,癫痫实验模型的大脑中和癫痫患者的切除脑组织中 P2X7R 蛋白水平增加。动物研究提供了证据表明,P2X7R 阻断可以减轻急性癫痫发作的严重程度和癫痫表型。本综述将简要总结最近关于 P2X7R 信号在癫痫发作和癫痫中的关键发现,重点介绍基于 P2X7R 的治疗作为治疗耐药性癫痫发作和癫痫的辅助治疗策略的潜在临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac7/11241490/d2eab6d715ae/ijms-25-06894-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac7/11241490/d2eab6d715ae/ijms-25-06894-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac7/11241490/d2eab6d715ae/ijms-25-06894-g001.jpg

相似文献

1
The Purinergic P2X7 Receptor as a Target for Adjunctive Treatment for Drug-Refractory Epilepsy.嘌呤能 P2X7 受体作为辅助治疗耐药性癫痫的靶点。
Int J Mol Sci. 2024 Jun 23;25(13):6894. doi: 10.3390/ijms25136894.
2
The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy.P2X7 受体作为癫痫的机制生物标志物。
Int J Mol Sci. 2023 Mar 12;24(6):5410. doi: 10.3390/ijms24065410.
3
Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy.短暂性P2X7受体拮抗作用可使实验性颞叶癫痫的自发性癫痫发作和胶质增生持续减少。
J Neurosci. 2016 Jun 1;36(22):5920-32. doi: 10.1523/JNEUROSCI.4009-15.2016.
4
How is the P2X7 receptor signaling pathway involved in epileptogenesis?P2X7 受体信号通路如何参与癫痫发生?
Neurochem Int. 2024 Feb;173:105675. doi: 10.1016/j.neuint.2024.105675. Epub 2024 Jan 10.
5
Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor.超越癫痫控制:通过靶向P2X7受体治疗癫痫共病
Int J Mol Sci. 2022 Feb 21;23(4):2380. doi: 10.3390/ijms23042380.
6
Opposing effects of the purinergic P2X7 receptor on seizures in neurons and microglia in male mice.嘌呤能 P2X7 受体对雄性小鼠神经元和小胶质细胞癫痫发作的相反作用。
Brain Behav Immun. 2024 Aug;120:121-140. doi: 10.1016/j.bbi.2024.05.023. Epub 2024 May 20.
7
Effects of P2X7 receptor antagonists on hypoxia-induced neonatal seizures in mice.P2X7 受体拮抗剂对缺氧诱导的新生鼠癫痫发作的影响。
Neuropharmacology. 2017 Apr;116:351-363. doi: 10.1016/j.neuropharm.2017.01.005. Epub 2017 Jan 10.
8
Critical Evaluation of P2X7 Receptor Antagonists in Selected Seizure Models.在选定癫痫模型中对P2X7受体拮抗剂的批判性评价
PLoS One. 2016 Jun 9;11(6):e0156468. doi: 10.1371/journal.pone.0156468. eCollection 2016.
9
Role of the purinergic signaling in epilepsy.嘌呤能信号传导在癫痫中的作用。
Pharmacol Rep. 2017 Feb;69(1):130-138. doi: 10.1016/j.pharep.2016.09.018. Epub 2016 Sep 22.
10
Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079.癫痫持续状态后新皮层 P2X7 受体表达增加及 P2X7 受体拮抗剂 A-438079 的抗惊厥作用。
Epilepsia. 2013 Sep;54(9):1551-61. doi: 10.1111/epi.12257. Epub 2013 Jun 28.

本文引用的文献

1
Opposing effects of the purinergic P2X7 receptor on seizures in neurons and microglia in male mice.嘌呤能 P2X7 受体对雄性小鼠神经元和小胶质细胞癫痫发作的相反作用。
Brain Behav Immun. 2024 Aug;120:121-140. doi: 10.1016/j.bbi.2024.05.023. Epub 2024 May 20.
2
Second-line immunotherapy in new onset refractory status epilepticus.二线免疫治疗新发耐药性癫痫持续状态。
Epilepsia. 2024 May;65(5):1203-1223. doi: 10.1111/epi.17933. Epub 2024 Mar 2.
3
Anti-seizure effects of JNJ-54175446 in the intra-amygdala kainic acid model of drug-resistant temporal lobe epilepsy in mice.
JNJ-54175446对小鼠杏仁核内注射海藻酸所致耐药性颞叶癫痫模型的抗癫痫作用
Front Pharmacol. 2024 Jan 8;14:1308478. doi: 10.3389/fphar.2023.1308478. eCollection 2023.
4
The neuroinflammatory astrocytic P2X7 receptor: Alzheimer's disease, ischemic brain injury, and epileptic state.神经炎症星形胶质细胞 P2X7 受体:阿尔茨海默病、缺血性脑损伤和癫痫状态。
Expert Opin Ther Targets. 2023 Jul-Dec;27(9):763-778. doi: 10.1080/14728222.2023.2258281. Epub 2023 Sep 15.
5
Microglia in epilepsy.癫痫中的小胶质细胞。
Neurobiol Dis. 2023 Sep;185:106249. doi: 10.1016/j.nbd.2023.106249. Epub 2023 Aug 1.
6
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder.在患有重度抑郁症的患者中,中枢神经系统渗透和选择性嘌呤 P2X7 受体拮抗剂 JNJ-54175446 的特征。
Transl Psychiatry. 2023 Jul 24;13(1):266. doi: 10.1038/s41398-023-02557-5.
7
Functional expression of the ATP-gated P2X7 receptor in human iPSC-derived astrocytes.人诱导多能干细胞源性星形胶质细胞中 ATP 门控 P2X7 受体的功能表达。
Purinergic Signal. 2024 Jun;20(3):303-309. doi: 10.1007/s11302-023-09957-8. Epub 2023 Jul 15.
8
Untangling Macropore Formation and Current Facilitation in P2X7.解开 P2X7 中大孔形成和电流促进的谜团。
Int J Mol Sci. 2023 Jun 30;24(13):10896. doi: 10.3390/ijms241310896.
9
Drug resistance in epilepsy.癫痫的耐药性。
Lancet Neurol. 2023 Aug;22(8):723-734. doi: 10.1016/S1474-4422(23)00151-5. Epub 2023 Jun 20.
10
The role of the adenosine system in epilepsy and its comorbidities.腺苷系统在癫痫及其共病中的作用。
Br J Pharmacol. 2024 Jul;181(14):2143-2157. doi: 10.1111/bph.16094. Epub 2023 May 8.